(Q34011793)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10954386%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

review article

1 reference

title

Signal transmission, rather than reception, is the underlying neurochemical abnormality in schizophrenia (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10954386%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10954386%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

author name string

B Dean

series ordinal

1

1 reference

30 July 2017

1 August 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10954386%20AND%20SRC:MED&resulttype=core&format=json

Australian and New Zealand Journal of Psychiatry

9 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10954386%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

volume

34

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10954386%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10954386%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

page(s)

560-569

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10954386%20AND%20SRC:MED&resulttype=core&format=json

Schizophrenia--a brain disease? A critical review of structural and functional cerebral abnormality in the disorder

9 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1080%2FJ.1440-1614.2000.00747.X

Biological studies in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2FJ.1440-1614.2000.00747.X

Increased brain dopamine and reduced glutamic acid decarboxylase and choline acetyl transferase activity in schizophrenia and related psychoses

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2FJ.1440-1614.2000.00747.X

Increased concentrations and lateral asymmetry of amygdala dopamine in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2FJ.1440-1614.2000.00747.X

Determination of monoamine and monoamine metabolites in the human brain: post mortem studies in a group of suicides and in a control group

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2FJ.1440-1614.2000.00747.X

Multiple receptors for dopamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2FJ.1440-1614.2000.00747.X

Molecular biology of dopamine receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2FJ.1440-1614.2000.00747.X

Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2FJ.1440-1614.2000.00747.X

Clozapine. A novel antipsychotic agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2FJ.1440-1614.2000.00747.X

Dopamine receptor transcript expression in striatum and prefrontal and occipital cortex. Focal abnormalities in orbitofrontal cortex in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2FJ.1440-1614.2000.00747.X

[3H]raclopride binding to brain tissue from subjects with schizophrenia: methodological aspects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2FJ.1440-1614.2000.00747.X

Elevation of D4 dopamine receptor mRNA in postmortem schizophrenic brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2FJ.1440-1614.2000.00747.X

No difference in the expression of the D4 gene in post-mortem frontal cortex from controls and schizophrenics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2FJ.1440-1614.2000.00747.X

Selective loss of dopamine D3-type receptor mRNA expression in parietal and motor cortices of patients with chronic schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2FJ.1440-1614.2000.00747.X

Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2FJ.1440-1614.2000.00747.X

Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: evidence from a novel positron emission tomography method

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2FJ.1440-1614.2000.00747.X

The evolution of the serotonin-dopamine antagonist concept

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2FJ.1440-1614.2000.00747.X

Neurotransmitter Receptors in Frontal Cortex of Schizophrenics

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2FJ.1440-1614.2000.00747.X

Decreased serotonin S2 and increased dopamine D2 receptors in chronic schizophrenics

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2FJ.1440-1614.2000.00747.X

Alterations in the cortical serotonergic system in schizophrenia: a postmortem study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2FJ.1440-1614.2000.00747.X

Decreased serotonin2A receptors in Brodmann's area 9 from schizophrenic subjects. A pathological or pharmacological phenomenon?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2FJ.1440-1614.2000.00747.X

5-HT1A and 5-HT2A receptor mRNAs and binding site densities are differentially altered in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2FJ.1440-1614.2000.00747.X

Serotonin 5-HT2 receptors in schizophrenia: a PET study using [18F]setoperone in neuroleptic-naive patients and normal subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2FJ.1440-1614.2000.00747.X

No serotonin 5-HT2A receptor density abnormality in the cortex of schizophrenic patients studied with PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2FJ.1440-1614.2000.00747.X

Selective abnormalities of prefrontal serotonergic receptors in schizophrenia. A postmortem study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2FJ.1440-1614.2000.00747.X

Serotonin1A receptors are increased in postmortem prefrontal cortex in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2FJ.1440-1614.2000.00747.X

Serotonin uptake sites and serotonin receptors are altered in the limbic system of schizophrenics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2FJ.1440-1614.2000.00747.X

No change in the density of the serotonin1A receptor, the serotonin4 receptor or the serotonin transporter in the dorsolateral prefrontal cortex from subjects with schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2FJ.1440-1614.2000.00747.X

Differential changes in serotonin 5-HT1A and 5-HT2 receptor binding in patients with chronic schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2FJ.1440-1614.2000.00747.X

Changes in the serotonin transporter in the hippocampus of subjects with schizophrenia identified using [3H]paroxetine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2FJ.1440-1614.2000.00747.X

Alterations in phencyclidine and sigma binding sites in schizophrenic brains. Effects of disease process and neuroleptic medication.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2FJ.1440-1614.2000.00747.X

Increased density of glutamate/N-methyl-D-aspartate receptors in putamen from schizophrenic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2FJ.1440-1614.2000.00747.X

NR2B-containing NMDA receptors are up-regulated in temporal cortex in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2FJ.1440-1614.2000.00747.X

Increased [3H]kainic acid binding in the prefrontal cortex in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2FJ.1440-1614.2000.00747.X

Frontal cortical and left temporal glutamatergic dysfunction in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2FJ.1440-1614.2000.00747.X

Neurotransmitters, receptors and neuropeptides in post-mortem brains of chronic schizophrenic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2FJ.1440-1614.2000.00747.X

Quantitative autoradiographic analysis of glutamate binding sites in the hippocampal formation in normal and schizophrenic brain post mortem

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2FJ.1440-1614.2000.00747.X

Alpha-[3H]amino-3-hydroxy-5-methylisoxazole-4-propionic acid binding to human cerebral cortical membranes: minimal changes in postmortem brains of chronic schizophrenics

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2FJ.1440-1614.2000.00747.X

Distribution of kainate receptor subunit mRNAs in human hippocampus, neocortex and cerebellum, and bilateral reduction of hippocampal GluR6 and KA2 transcripts in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2FJ.1440-1614.2000.00747.X

Immunoautoradiographic evidence for a loss of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate-preferring non-N-methyl-D-aspartate glutamate receptors within the medial temporal lobe in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2FJ.1440-1614.2000.00747.X

Measurement of glutamate and glutamine in the medial prefrontal cortex of never-treated schizophrenic patients and healthy controls by proton magnetic resonance spectroscopy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2FJ.1440-1614.2000.00747.X

Regionally selective deficits in uptake sites for glutamate and gamma-aminobutyric acid in the basal ganglia in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2FJ.1440-1614.2000.00747.X

Deficits of [3H]D-aspartate binding to glutamate uptake sites in striatal and accumbens tissue in patients with schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2FJ.1440-1614.2000.00747.X

gamma-Aminobutyric acid (Gaba) and the dopamine hypothesis of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2FJ.1440-1614.2000.00747.X

Gamma-aminobutyric-acid deficiency in brain of schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2FJ.1440-1614.2000.00747.X

Chronic GABA treatment downregulates the GABAA receptor alpha 2 and alpha 3 subunit mRNAS as well as polypeptide expression in primary cultured cerebral cortical neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2FJ.1440-1614.2000.00747.X

Up-regulation of GABAA receptor binding on neurons of the prefrontal cortex in schizophrenic subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2FJ.1440-1614.2000.00747.X

Changes in serotonin2A and GABA(A) receptors in schizophrenia: studies on the human dorsolateral prefrontal cortex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2FJ.1440-1614.2000.00747.X

Differences in the subregional and cellular distribution of GABAA receptor binding in the hippocampal formation of schizophrenic brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2FJ.1440-1614.2000.00747.X

Benzodiazepine receptors in the post-mortem brain of suicide victims and schizophrenic subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2FJ.1440-1614.2000.00747.X

Reduced [3H]flunitrazepam binding in cingulate cortex and hippocampus of postmortem schizophrenic brains: is selective loss of glutamatergic neurons associated with major psychoses?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2FJ.1440-1614.2000.00747.X

GABAA receptor subunit gene expression in human prefrontal cortex: comparison of schizophrenics and controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2FJ.1440-1614.2000.00747.X

Altered ratios of alternatively spliced long and short gamma2 subunit mRNAs of the gamma-amino butyrate type A receptor in prefrontal cortex of schizophrenics

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2FJ.1440-1614.2000.00747.X

Correlation between reduced in vivo benzodiazepine receptor binding and severity of psychotic symptoms in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2FJ.1440-1614.2000.00747.X

Cognitive functioning and GABAA/benzodiazepine receptor binding in schizophrenia: a 123I-iomazenil SPET study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2FJ.1440-1614.2000.00747.X

Deficit and hemispheric asymmetry of GABA uptake sites in the hippocampus in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2FJ.1440-1614.2000.00747.X

Schizophrenia and the parvalbumin-containing class of cortical local circuit neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2FJ.1440-1614.2000.00747.X

Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2FJ.1440-1614.2000.00747.X

Abnormal regulation of corticopetal cholinergic neurons and impaired information processing in neuropsychiatric disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2FJ.1440-1614.2000.00747.X

Olanzapine versus haloperidol in the treatment of schizophrenia and schizoaffective and schizophreniform disorders: results of an international collaborative trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2FJ.1440-1614.2000.00747.X

Radioreceptor binding profile of the atypical antipsychotic olanzapine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2FJ.1440-1614.2000.00747.X

Possible changes in striatal and limbic cholinergic systems in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2FJ.1440-1614.2000.00747.X

Various enzymes involved with putative neurotransmitters. Regional distribution in the brain of deceased mentally normal, chronic schizophrenics or organic brain syndrome patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2FJ.1440-1614.2000.00747.X

Choline acetyltransferase in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2FJ.1440-1614.2000.00747.X

Increased muscarinic cholinergic receptors in prefrontal cortices of medicated schizophrenics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2FJ.1440-1614.2000.00747.X

Muscarinic1 and 2 receptor mRNA in the human caudate-putamen: no change in m1 mRNA in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2FJ.1440-1614.2000.00747.X

The structural era of endocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2FJ.1440-1614.2000.00747.X

(3H]MK-801 binding sites in postmortem brain regions of schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2FJ.1440-1614.2000.00747.X

Autoradiography with [3H]8-OH-DPAT reveals increases in 5-HT1A receptors in ventral prefrontal cortex in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2FJ.1440-1614.2000.00747.X

10.1080/J.1440-1614.2000.00747.X

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10954386%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1 reference